27.07.2013 Views

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

400 ALTERATIONS OF SIGNALING PROTEIN<br />

INTERACTIONS IN RESPONSE TO INCREASING DOSE.<br />

C. Kinzer, H. Williams, X. Gao, N. Rubenstein, A. Cook, J. Vrana and J.<br />

Boyd. Bennett Department <strong>of</strong> Chemistry, West Virginia University, Morgantown, WV.<br />

Although current understanding <strong>of</strong> signal transduction within biological networks<br />

is based upon changes in protein phosphorylation over time, cells are also responsive<br />

to increasing doses <strong>of</strong> inhibitors independent <strong>of</strong> time. By assessing the functional<br />

response <strong>of</strong> a cellular network to increasing doses <strong>of</strong> inhibitors, additional information<br />

can be gained about the relationships and roles <strong>of</strong> proteins in response to<br />

cellular stress. To determine the direction <strong>of</strong> information flow in a cellular network<br />

in response to stress, the phosphorylation activity <strong>of</strong> several protein kinases within<br />

the mitogen-activated protein kinase (MAPK) pathways were monitored. HepG2<br />

cells were exposed to increasing doses <strong>of</strong> deguelin, and KCN. Correlation and protein<br />

activity were quantified using multiplex phosphoprotein assays on lysates obtained<br />

400 minutes after dosing. <strong>The</strong> resulting correlation analysis across all dosing<br />

intervals was in general agreement with accepted temporal models <strong>of</strong> signal transduction.<br />

However, correlation values compared on a dose-to-dose level differed significantly<br />

from the temporal model and revealed surprising changes in specificity<br />

among protein kinases. This preliminary analysis into interactions <strong>of</strong> signaling proteins<br />

in response to increasing dose <strong>of</strong>fers a unique way <strong>of</strong> framing cellular network<br />

relationships in biochemical networks, and holds the potential to aid in the eventual<br />

prediction <strong>of</strong> toxicity by identifying cellular strategies for adaptation and survival.<br />

401 IMPACT OF ENERGY METABOLISM ON THE DESIGN<br />

OF KINASE-TARGETED THERAPEUTICS.<br />

A. Cook, H. Williams, X. Gao and J. Boyd. Bennett Department <strong>of</strong> Chemistry,<br />

West Virginia University, Morgantown, WV.<br />

Protein kinases play key roles in signaling pathways that regulate cellular functions<br />

such as proliferation and apoptosis. Due to the potential regulatory control over<br />

such important biological processes, interest in kinase-targeted chemotherapeutics<br />

has grown exponentially in the drug discovery arena. Current drug design is aimed<br />

at developing substrate-competitive kinase inhibitors, which are thought to <strong>of</strong>fer<br />

higher selectivity and sensitivity over ATP-competitive kinase inhibitors that must<br />

compete with intracellular ATP concentrations. However, what has not been explored<br />

as comprehensively is the impact that these inhibitors can have on energy<br />

metabolism. This study seeks to investigate the activity <strong>of</strong> two different AKT and<br />

GSK3 inhibitors, substrate-competitive versus an ATP-competitive, in relation to<br />

glycolysis and oxygen consumption. Our results suggest that beyond the effects <strong>of</strong><br />

inhibiting metabolically-linked proteins, ATP-competitive inhibitors may alter intracellular<br />

interpretation <strong>of</strong> available ATP which leads to decreases in compensatory<br />

energy metabolism and could result in greater toxicity.<br />

402 cAMP-DEPENDENT PATHWAY(S) INCREASE P27 KIP -<br />

CYCLIN D1 THROUGH THE RAP-GTP/B-RAF MAPK<br />

SIGNALING PATHWAY IN RENAL CANCER.<br />

N. Mastrandrea, K. Y. Tham, J. D. Cohen, T. J. Monks and S. S. Lau.<br />

Pharmacology/<strong>Toxicology</strong>, University <strong>of</strong> Arizona, Tucson, AZ.<br />

<strong>The</strong> Eker rat (Tsc-2EK/+) bears a germline mutation in the tuberous sclerosis-2<br />

(Tsc-2) tumor-suppressor gene, and can undergo spontaneous and chemically induced<br />

loss <strong>of</strong> heterozygosity. Renal tumors null for tuberin, the Tsc-2 gene product,<br />

derived from 2,3,5-tris-(glutathion-S-yl)hydroquinone (TGHQ) treated Tsc-<br />

2EK/+ rats, display elevated p27 and cyclin D1 levels. Similar elevations were observed<br />

in TGHQ transformed QTRRE renal epithelial cells derived from Tsc-<br />

2EK/+ rats, which also exhibit high ERK, B-Raf and Raf-1 kinase activities. p27<br />

signaling pathways, especially those associated with its binding partner, cyclin D1,<br />

are relatively unknown. In QTRRE cells cAMP signaling regulates both p27 expression<br />

and Rap-GTP/B-Raf activation <strong>of</strong> the MAP kinase cascade. We now report<br />

that dibutyryl cAMP (db-cAMP; 1mM) or the phosphodiesterase inhibitor,<br />

theophylline (0.6 mg/ml), produced a time-dependent increase in p27 protein levels<br />

(1.4, 2.0, 3.0 fold, and 1.6, 2.8, 2.4 fold at 2, 10 and 24 hrs, respectively). A<br />

concomitant increase in cyclin D1 levels was also observed in db-cAMP and theophylline<br />

treated QTRRE cells. Inhibition <strong>of</strong> Raf kinases, with either sorafenib (50<br />

μM) or B-Raf siRNA resulted in MAPK down-regulation <strong>of</strong> p27. Moreover, following<br />

a 48 hr treatment <strong>of</strong> QTRRE cells with p27 siRNA there was an equivalent<br />

88% decrease in both p27 and cyclin D1 protein levels; similarly, a 48 hr treatment<br />

with cyclin D1 siRNA resulted in a concomitant 50% decrease in p27 protein levels,<br />

suggesting that the p27-cyclin D1 complex promotes preservation <strong>of</strong> both proteins.<br />

Collectively these data reveal that the cAMP/Rap1b/B-Raf pathway modulates<br />

the expression <strong>of</strong> p27 and cyclin D1 in Tsc-2 gene regulated-renal cancer.<br />

86 SOT 2011 ANNUAL MEETING<br />

<strong>The</strong>refore, the loss <strong>of</strong> tuberin and engagement <strong>of</strong> the cAMP pathway may independently<br />

direct p27-cyclin D1 stabilization during renal tumor formation.<br />

(P30ES006694, T32ES007091, AstraZeneca Studentship)<br />

403 EFFECT OF P, P’-DDE ON JAK2, STAT1α, AND NFκB<br />

ACTIVATION IN MACROPHAGES J774A.1.<br />

N. A. Torres-Aviles 1 , L. C. Acosta-Saavedra 1 , A. L. Luna 1 , E. K. Silbergeld 2 and<br />

E. S. Calderon-Aranda 1 . 1 Department .Toxicologia, Cinvestav, Mexico, Mexico and<br />

2 BSPH, Johns Hopkins University, Baltimore, MD.<br />

DDE(dichloro-diphenyl-dichloroethylene) is the most persistent metabolite <strong>of</strong><br />

DDT since it has been found in high concentration in the serum <strong>of</strong> people <strong>of</strong> region<br />

where DDT was used. In macrophages J774A.1 activated with IFN-γ or LPS,<br />

p,p’-DDE reduced nitric oxide (NO -) production and iNOS gene expression, as<br />

well as bactericide ability against Mycobacterium microti, suggesting that both<br />

pathways share molecules targeted by p,p’-DDE. <strong>The</strong> iNOS gene transcription is<br />

regulated by NFκB and STAT1α,activated by LPS and IFN-γ pathway, respectively,<br />

however, it has shown that in dendritic cells, among others, JAK2, a kinase<br />

involved in canonical activation <strong>of</strong> STAT1α, participates in the activation pathway<br />

<strong>of</strong> NF-κB. <strong>The</strong> objective <strong>of</strong> this study was to assess whether JAK2 is a molecular<br />

target <strong>of</strong> p,p’-DDE in macrophages activated with LPS, to explain, at least partially,<br />

the mechanism <strong>of</strong> decreasing <strong>of</strong> NO - production. Methods In J774A.1<br />

macrophages activated with LPS was evaluated the effect <strong>of</strong> one hour pre-exposure<br />

to 2.5 μg/ml p,p’-DDE on the activation <strong>of</strong> JAK2, STAT-1α and NF-κB by<br />

Western blot, and NO -, determined by the Griess method. Results shown that the<br />

p,p’-DDE inhibits NO - production in LPS-activated cells and that JAK2 activation<br />

is involved in LPS-induced production <strong>of</strong> NO -; in non exposed cells LPS induces<br />

phosphorylation <strong>of</strong> JAK2/STAT-1α, while p,p’-DDE in activated cells, overinduced<br />

JAK2/STAT-1α, but reduced NF-kB activation induced by<br />

LPS,suggesting that this effect is non-dependent <strong>of</strong> over-activation <strong>of</strong> JAK2; p,p’-<br />

DDE in non activated cells induces JAK2/STAT-1α pathway. Taken together our<br />

results show that the inhibition <strong>of</strong> NO - production is at least partially dependent<br />

<strong>of</strong> the inhibition <strong>of</strong> the iNOS gene activation via <strong>of</strong> NF-κB, but this effect is not related<br />

with the effect <strong>of</strong> p,p’-DDE on JAK2, but more studies about the mechanisms<br />

<strong>of</strong> inhibition <strong>of</strong> p,p’-DDE in the functional activation <strong>of</strong> macrophages are needed.<br />

This work was supported by Conacyt-46297.<br />

404 A ROLE FOR STRESS-RESPONSIVE SIGNALING IN THE<br />

REGULATION OF ERK OSCILLATIONS.<br />

T. J. Weber 1 , H. Shankaran 2 , K. M. Waters 2 , W. B. Chrisler 1 and R. L. Sontag 1 .<br />

1 Cell Biology & Biochemistry, PNNL, Richland, WA and 2 Computational Biology,<br />

PNNL, Richland, WA.<br />

Deregulation <strong>of</strong> feedback control processes by stress-responsive signaling can play<br />

an important role in pathophysiology. We have recently demonstrated that the extracellular<br />

signal regulated kinase (ERK) displays persistent nuclear-cytosolic oscillations<br />

in response to tyrosine kinase receptor ligands (EGF, bFGF) in mouse and<br />

human cell systems. ERK oscillations are inhibited by ≥ 0.32 hydrogen peroxide<br />

and 10 cGy X-irradiation, doses that do not produce observable decrease in cell viability<br />

using a neutral red assay. Antibiotics used to select for transduced cells expressing<br />

selectable markers inhibit ERK oscillations in both reversible (normal immortalized<br />

human keratinocytes) and irreversible (primary human keratinocytes)<br />

fashion. We confirmed that X-irradiation induces an increase in phospho-p38 levels<br />

by Western blot and p38 is frequently activated in response to a broad range <strong>of</strong><br />

cell stressors. Growth factor-dependent ERK oscillations can be restored in a subset<br />

<strong>of</strong> non-oscillating cells by an inhibitor <strong>of</strong> p38 kinase (SB203580). Collectively,<br />

these observations demonstrate that 1) ERK oscillations are inhibited by hydrogen<br />

peroxide and X-irradiation at low dose exposures, 2) ERK oscillations can be restored<br />

in non-oscillating cells by a p38 kinase inhibitor and 3) standard practices<br />

for maintaining and engineering cells can disrupt ERK oscillations potentially contributing<br />

to inter-laboratory biological variability. <strong>The</strong> disruption <strong>of</strong> ERK oscillations<br />

represents a putative new mode-<strong>of</strong> action by which toxicological agents can<br />

perturb biological systems.<br />

405 HARMINE MODULATES DIOXIN-INDUCED CYP1A1<br />

ENZYME THROUGH TRANSCRIPTIONAL AND POST-<br />

TRANSLATIONAL MECHANISMS.<br />

M. El Gendy and A. El-Kadi. Faculty <strong>of</strong> Pharmacy and Pharmaceutical Sciences,<br />

University <strong>of</strong> Alberta, Edmonton, AB, Canada.<br />

Dioxins are widespread environmental contaminants that induce the carcinogenactivating<br />

enzyme cytochrome P450 1A1 (CYP1A1) through an aryl hydrocarbon<br />

receptor (AhR)-dependent mechanism. Harmine is a common β-carboline present<br />

in several medicinal plants such as Peganum harmala. Harmine possesses antitumor

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!